| Literature DB >> 18996259 |
F U Chowdhury1, K M Bradley, F V Gleeson.
Abstract
Integrated positron-emission tomography/computed tomography (PET/CT) with 2-[fluorine-18] fluoro-2-deoxy-D-glucose (FDG) is now established in the management of oncology patients. With increasing availability and a constantly advancing body of evidence, the role of FDG PET/CT in oesophageal cancer is set to expand to include initial staging, assessment of disease response, therapy planning, and detection of disease recurrence. This article reviews the utility of FDG PET/CT in the management of oesophageal carcinoma, discussing its role and limitations in the imaging of these patients.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18996259 DOI: 10.1016/j.crad.2008.05.010
Source DB: PubMed Journal: Clin Radiol ISSN: 0009-9260 Impact factor: 2.350